immatics biotechnologies Funding: $312M Raised, Other Equity
immatics biotechnologies is based in Tuebingen, Germany. It has raised $312M in total funding. Latest round: Other Equity.
immatics biotechnologies funding overview
immatics biotechnologies is based in Tuebingen, Germany. immatics biotechnologies has raised $312M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an Other Equity announced in August 2019. The round record for immatics biotechnologies runs through 2019; nothing later has been disclosed. Investors on record include Celgene, Wellington Partners, Amgen Ventures, AT Impf, Dievini Hopp Biotech Holding, MIG Capital and 1 others. 7 distinct backers are named across the disclosed rounds.
Frequently asked about immatics biotechnologies funding
How much has immatics biotechnologies raised?
immatics biotechnologies has raised $312M in total disclosed funding across the rounds on record.
Who has invested in immatics biotechnologies?
Celgene, Wellington Partners, Amgen Ventures, AT Impf, Dievini Hopp Biotech Holding, MIG Capital are named among the investors backing immatics biotechnologies.
What was the latest immatics biotechnologies funding round?
The most recent disclosed round is an Other Equity, announced in August 2019.
Where is immatics biotechnologies based?
immatics biotechnologies is based in Tuebingen, Germany.
When did immatics biotechnologies last raise?
The last disclosed immatics biotechnologies round closed in August 2019 at Other Equity.
immatics biotechnologies totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Tuebingen below to benchmark round size and investor mix.
Companies related to immatics biotechnologies (34)
